Technical Analysis for ICAD - icad inc.

Grade Last Price % Change Price Change
grade D 4.19 -0.24% -0.01
ICAD closed unchanged on Thursday, March 21, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ICAD trend table...

Date Alert Name Type % Chg
Mar 21 NR7 Range Contraction -0.24%
Mar 21 Doji - Bullish? Reversal -0.24%
Mar 21 Wide Bands Range Expansion -0.24%
Mar 21 Oversold Stochastic Weakness -0.24%
Mar 20 Stochastic Reached Oversold Weakness -0.24%
Mar 20 Wide Bands Range Expansion -0.24%
Mar 20 Oversold Stochastic Weakness -0.24%
Mar 19 Earnings Movers Other -8.91%
Mar 19 Wide Bands Range Expansion -8.91%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.89%

Older signals for ICAD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy that enable healthcare professionals and radiologists to identify pathologies and pinpoint cancer earlier. It offers Axxent eBx system, which is used for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated. It also provides computer-aided detection (CAD) solutions for digital and film-based mammography systems, including SecondLook systems that detects and identifies masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to PACS and/or review workstations. In addition, the company offers image analysis and workflow solutions in MRI imaging comprising SpectraLook for breast, VividLook for prostate, and OmniLook for other organs; and VersaVue Enterprise, a review and reporting solution, which provides visual and quantitative depictions of the movement of contrast agent through a lesion. Further, it provides VeraLook that supports the detection of colonic polyps in conjunction with CT Colonography; and the TotalLook MammoAdvantage system, a mammography specific digitizer. The company sells its products to hospitals, ambulatory care centers, and free standing radiation oncology facilities. It sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.
Medicine Health Cancer Imaging Cancers Radiation Breast Cancer Medical Imaging Radiation Therapy Healthcare Professionals CAD MRI Workflow Solutions Cancer Screening Mammography Skin Cancer Breast Imaging Endometrial Cancer Picture Archiving And Communication System
Is ICAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.1
52 Week Low 2.425
Average Volume 181,237
200-Day Moving Average 3.6196
50-Day Moving Average 4.9619
20-Day Moving Average 4.7638
10-Day Moving Average 4.428
Average True Range 0.4023
ADX 18.25
+DI 11.7896
-DI 18.5635
Chandelier Exit (Long, 3 ATRs ) 4.6931
Chandelier Exit (Short, 3 ATRs ) 5.3369
Upper Bollinger Band 5.6104
Lower Bollinger Band 3.9172
Percent B (%b) 0.17
BandWidth 35.543054
MACD Line -0.195
MACD Signal Line -0.1413
MACD Histogram -0.0537
Fundamentals Value
Market Cap 69.7 Million
Num Shares 16.6 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -7.50
Price-to-Sales 2.98
Price-to-Book 3.16
PEG Ratio -0.58
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.53
Resistance 3 (R3) 4.54 4.45 4.48
Resistance 2 (R2) 4.45 4.36 4.44 4.46
Resistance 1 (R1) 4.32 4.31 4.31 4.31 4.44
Pivot Point 4.23 4.23 4.22 4.22 4.23
Support 1 (S1) 4.10 4.14 4.09 4.09 3.96
Support 2 (S2) 4.01 4.09 4.00 3.94
Support 3 (S3) 3.88 4.01 3.93
Support 4 (S4) 3.87